Evidence map›Paper›PMID 38799342›Full record

ArticleACS omega2024

Zeeshan Jabbar, Hafiz M Irfan, Alamgeer, Aman Ullah, Mohamed H Mahmoud, Gaber E Batiha, Haseeb Ahsan, Ajmal Khan, Hamdy Kashtoh

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Journal of inflammation research · 2026
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zeeshan JabbarCollege of Pharmacy, University of Sargodha, 40100 Sargodha, Pakistan.
Hafiz M IrfanCollege of Pharmacy, University of Sargodha, 40100 Sargodha, Pakistan.ORCID https://orcid.org/0000-0003-0572-2072
AlamgeerPunjab University College of Pharmacy, University of the Punjab, 54000 Lahore, Pakistan.
Aman UllahDepartment of Pharmacy, Saba Medical Centre, Abu Dhabi P.O. Box 20316, United Arab Emirates.
Mohamed H MahmoudDepartment of Biochemistry, College of science, King Saud University, 4545 Riyadh, Kingdom of Saudi Arabia.
Gaber E BatihaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511 AlBeheira, Egypt.
Haseeb AhsanDivision of Blood and Marrow Transplantation, Department of Pediatrics, School of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Ajmal KhanNatural and Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman.
Hamdy KashtohDepartment of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune disorders include vast and distinct illnesses and are characterized by an immune system-mediated attack on the body's own tissues. Because of their ability to impact any portion of the body, their clinical symptoms are incredibly varied. The variations in symptoms are normally linked with the release and activation of vasoactive, chemotactic substances and cytokines. Cytokines perform a multitude of vital biological tasks, such as immune response control, inflammation, proliferation, and tissue repair. The reversal of inflammatory cytokines and leukocyte infiltration into the inflamed tissue by natural compounds provides an effective remedy for autoimmune diseases. Here, the oral administration of

Identifiers

PMID38799342
PMCPMC11112584

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.